RAPT: RAPT Therapeutics, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
FDA tasdig'ini kutish va immun molekulalari sinovlarining qayta ishga tushirilishi o'sish potentsialini yaratmoqda, buni GURU.Markets platformasidagi o'sishga moslashtirilgan P/E grafigi 0.00 orqali vizuallashtirib, joriy darajani ko'rsatmoqda. RAPT Therapeutics, Inc. (RAPT) saraton va yallig'lanishga qarshi og'iz orqali qabul qilinadigan, maxsus retseptorlarni bloklashga qaratilgan davolash vositalarini ishlab chiqadi. Hamkorlik grantlari va tashqi investitsiyalar ushbu startapning moliyalashtirilishini ta'minlaydi.
RAPT Therapeutics (RAPT) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati RAPT Therapeutics, Inc.|RAPT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi RAPT Therapeutics Inc.|RAPT - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar RAPT|RAPT - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari RAPT Therapeutics|Tezkor likvidlik koeffitsiyenti rapt.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
RAPT - Kompaniyaning sof foydasi|Forvard foyda RAPT Therapeutics, Inc.|RAPT - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati rapt.com|RAPT - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati RAPT|RAPT - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda RAPT Therapeutics|RAPT - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi rapt.com|RAPT - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi RAPT Therapeutics, Inc.
Kompaniyaning umumiy tahlili:RAPT - rapt.com
Ushbu ko'rsatkich P/E koeffitsiyentining foyda o'sish sur'atiga nisbati sifatida hisoblanadi va bu kelajakdagi biznes o'sishining har bir birligi xarajatlarini baholash imkonini beradi. PEG koeffitsiyentini tahlil qilish orqali investor aktivning fundamental past baholanganligini aniqlashi mumkin, bu esa RAPT Therapeutics, Inc. (RAPT) va uning immun tizimi buzilishlari terapiyasi sohasida grantlar hamda sherikliklar orqali maqsadli molekulalarni ishlab chiqish modelining muhim ahamiyatga ega.
RAPT Therapeutics, Inc. raqobatchilari
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PHVS (Pharvaris Pharma)|ABCL: PEG multiplikatori|tourmalinebio.com (TRML) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|Pharming Group NV - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati UPB|Zenas Biopharma Inc - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti IMNM|GOSS: Narx-foyda va o‘sish multiplikatori|KalVista Pharma - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|SEPN: PEG multiplikatori|Pieris Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda rigel.com RIGL|Narxning foydaga va o‘sish sur’atiga nisbati AnaptysBio (ANAB)|ATXS (Astria Therapeutics Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ENGN (enGene Bio)|PEG multiplikatori Aerovate Therapeutics, Inc. JBIO|ACRS - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati KYTX|TLSA: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Cabaletta Bio Inc. (CABA)|Narx-foyda va o‘sish multiplikatori VTYX|PEG multiplikatori Theratechnologies, Inc|Narx-foyda va o‘sish multiplikatori AVTX (Avalo Therapeutics, Inc)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati ELDN|PEG multiplikatori AGEN (Agenus Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Climb Bio Inc. (CLYM)|Zura Bio Limited - PEG multiplikatori|aTyr Pharmaceuticals (ATYR) - Narx-foyda va o‘sish multiplikatori|adagene.com (ADAG) - Narxning foydaga va o‘sish sur’atiga nisbati|IMA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori STTK|EQ: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CNTB|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunic-therapeutics.com|Narxning foydaga va o‘sish sur’atiga nisbati Atara Bio ATRA|IFRX: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|X4 Pharmaceuticals, Inc. - PEG multiplikatori|Adicet Bio (ACET) - Narx-foyda va o‘sish multiplikatori|CELU (celularity.com) - Narx-foyda va o‘sish multiplikatori|INMB - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|KZR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SABS|PEG multiplikatori Akari Therapeutics PLC (AKTX)|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB (Q32 Bio Inc) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|GOVX: Narx-foyda va o‘sish multiplikatori|edesabiotech.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati CARM (Carisma Therapeutics Inc.)|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|BOLT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HCWB|PEG multiplikatori aptevotherapeutics.com (APVO)|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XORTX Corp (XRTX) - Narx-foyda va o‘sish multiplikatori|HIND: PEG multiplikatori|revbiosciences.com (REVB) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori INDP|SCNI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CALI|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati affimed.com|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|iTeos Therapeutics Inc (ITOS) - Narx-foyda va o‘sish multiplikatori|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|TC BioPharm Ltd (TCBP) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
